MARK-B™ COVID-19 Antigen Test
Simple . Accurate . Fast .
The MARK-B™ COVID-19 Ag test is a electrochemical sandwich immunoassay that is used with the MARK-B™ 1 analyzer intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens.
*The MARK-B™ 1 analyzer(MB-100) and the MARK-B™ COVID-19 Ag are CE marked.
Benefits : COVID-19 antigen test
Deliver lab-quality results in 15 mins.
Test results in 15 minutes
Fast diagnosis with results in 15 minutes in various locations such as clinical laboratories, hospitals etc.
The clinical performance of MARK-B™ COVID-19 Ag was established with a study using NPS specimens, which have been previously characterized and were supplied by a biorepository in the United States. In the clinical performance, seventy-two (72) samples were measured, resulting in a sensitivity of 94.4% (34/36) and a specificity of 100.0% (36/36).
Enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.
Limit of Detection
2.39 x 10 TCID /mL
Detect a positive result against the low concentration sample without amplification before any symptom onset.
*The MARK-B™ COVID-19 Ag test cartridge. It's disposable.
Direct sample types include: Nasopharyngeal swabs
Simple operation via visual touchscreen
Assay kit contains all necessary components for testing to include: 25 test cartridges, swabs for sample collection, reagent solution kits
Actionable results in 15 minutes or less
Benefits : MARK-B™ 1 analyzer
Every infectious disease test needs quick answers. That’s why you need MARK-B™ 1 analyzer; a high-performance immunoassay analyzer that provides accurate results in minutes, not hours.
Easy to learn and use only minimal training requirements
Small footprint saves you bench space
Can be used in any healthcare setting
Large visual touchscreen displays results
Eliminating transcription errors and the need for printing
No need for calibration
Facilitates effective patient management
*The MARK-B™ 1 analyzer(MB-100) is CE marked.